CJC-1295 (No DAC)
(Short-Acting GHRH Analog)
CJC-1295 (No DAC) is a research peptide derived from growth hormone-releasing hormone (GHRH), studied for its role in promoting natural growth hormone pulses without prolonged systemic elevation. It is often utilized in short-duration research models. Areas of investigation include:
-
Physiologic GH Pulse Stimulation
CJC-1295 (No DAC) is being studied for its ability to enhance endogenous growth hormone release in a controlled, short-acting fashion. -
Recovery and Regeneration
Researchers are exploring its role in supporting tissue repair, muscle recovery, and cellular restoration. -
Anti-Aging and Hormonal Support
The compound is under investigation for its potential to address age-related GH decline and its downstream effects on performance and health.
How It Works
CJC-1295 (No DAC) is a short-acting analog of GHRH that binds to GHRH receptors on the anterior pituitary gland, stimulating the release of endogenous growth hormone. Unlike its DAC-containing counterpart, this version has a significantly shorter half-life (approx. 30 minutes), allowing for more physiologic, pulsatile GH secretion. It is commonly studied alone or in combination with other secretagogues like Ipamorelin to emulate the body’s natural hormone rhythms while supporting repair, recovery, and metabolic function.
⚠️ Important Notice:
This product is sold strictly for laboratory research purposes only. It is not for human or animal use, and not for therapeutic or diagnostic applications.
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations.
